• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胸腺切除术后发生再生障碍性贫血经免疫抑制治疗成功治愈]

[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].

作者信息

Sada Eriko, Shiratsuchi Motoaki, Ohno Hirofumi, Nagasawa Eriko, Honda Emi, Takayanagi Ryoichi, Abe Yasunobu

机构信息

Department of Medicine and Bioregulatory Science, Kyushu University, Kyushu, Japan.

出版信息

Rinsho Ketsueki. 2011 May;52(5):293-8.

PMID:21646776
Abstract

We report here a very severe case of thymoma-related aplastic anemia that developed after thymectomy. The patient was a 50-year-old man diagnosed with myasthenia gravis. Chest CT showed thymoma measuring 7.5 cm in diameter, and extended thymectomy was performed. Irradiation to the anterior mediastinum was added postoperatively. Thirteen months after surgery, hemogram showed severe neutropenia: leukocyte count 0.32×10(9)/l with 11% neutrophils; Hb 10.7 g/dl; and platelet count 100×10(9)/l. Although cyclosporine (CSP, 5 mg/kg/day) was administered, dose reduction was necessary because of renal damage. Cytopenia deteriorated to a leukocyte count of 0.71×10(9)/l with 21% neutrophils; Hb 5.9 g/dl; and platelet count 24×10(9)/l. However, addition of antithymocyte globulin (ATG, 15 mg/kg) led to hematopoietic recovery of all three lineages within one month. He is clinically stable with no transfusion requirement after 22 months with CSP maintenance therapy. Although thymoma-related aplastic anemia has been reported to have an extremely poor prognosis, high efficacy of CSP has been reported recently. In our case, ATG in combination with CSP was efficient. Adequate immunosuppressive therapy seems to be important for the clinical management of these patients.

摘要

我们在此报告一例胸腺切除术后发生的极为严重的胸腺瘤相关再生障碍性贫血病例。患者为一名50岁男性,诊断为重症肌无力。胸部CT显示直径7.5厘米的胸腺瘤,遂行扩大胸腺切除术。术后加行前纵隔放疗。术后13个月,血常规显示严重中性粒细胞减少:白细胞计数0.32×10⁹/L,中性粒细胞占11%;血红蛋白10.7 g/dl;血小板计数100×10⁹/L。尽管给予环孢素(CSP,5毫克/千克/天)治疗,但因肾损害需减少剂量。血细胞减少恶化,白细胞计数降至0.71×10⁹/L,中性粒细胞占21%;血红蛋白5.9 g/dl;血小板计数24×10⁹/L。然而,加用抗胸腺细胞球蛋白(ATG,15毫克/千克)后,所有三个血细胞系在1个月内实现造血恢复。在接受CSP维持治疗22个月后,他临床稳定,无需输血。尽管胸腺瘤相关再生障碍性贫血的预后据报道极差,但最近有报道称CSP疗效显著。在我们的病例中,ATG联合CSP有效。充分的免疫抑制治疗对这些患者的临床管理似乎很重要。

相似文献

1
[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].[胸腺切除术后发生再生障碍性贫血经免疫抑制治疗成功治愈]
Rinsho Ketsueki. 2011 May;52(5):293-8.
2
Thoracoscopic extended thymothymectomy for myasthenia gravis with aplastic anemia.胸腔镜扩大胸腺切除术治疗重症肌无力合并再生障碍性贫血
Ann Thorac Cardiovasc Surg. 2009 Oct;15(5):328-31.
3
[A case of myasthenia gravis developing after resection of non-invasive thymoma].
Kyobu Geka. 1993 Apr;46(4):367-9.
4
Aplastic Anemia Secondary to Thymectomy in a Patient With Myasthenia Gravis.重症肌无力患者胸腺切除术后再生障碍性贫血。
Ann Thorac Surg. 2020 Sep;110(3):e173-e175. doi: 10.1016/j.athoracsur.2020.01.044. Epub 2020 Mar 2.
5
[Aplastic anemia in thymoma].[胸腺瘤中的再生障碍性贫血]
Med Klin. 1972 Nov 10;67(45):1477-9.
6
[Thymothymectomy for the thymoma with pure red cell aplasia; report of a case].[胸腺切除术治疗合并纯红细胞再生障碍性贫血的胸腺瘤;1例报告]
Kyobu Geka. 2004 Aug;57(9):905-9.
7
[Surgery for the thymoma combined with pure red cell aplasia and myasthenia gravis].胸腺瘤合并纯红细胞再生障碍性贫血及重症肌无力的外科治疗
Kyobu Geka. 2005 Nov;58(12):1023-9; discussion 1029-31.
8
Myasthenia gravis with thymoma and autoimmune haemolytic anaemia. A case report.重症肌无力合并胸腺瘤及自身免疫性溶血性贫血。病例报告。
Neurol Sci. 2003 Apr;24(1):34-6. doi: 10.1007/s100720300019.
9
[A case of a small thymoma associated with myasthenia gravis in which the tumor was reduced by corticosteroid therapy].[一例小胸腺瘤合并重症肌无力,经皮质类固醇治疗后肿瘤缩小]
Nihon Kyobu Geka Gakkai Zasshi. 1992 Jun;40(6):975-7.
10
Fulminant myasthenia gravis manifested after removal of anterior mediastinal tumor.
Ann Thorac Surg. 1996 Nov;62(5):1534-6. doi: 10.1016/0003-4975(96)00605-4.